Xiyang Liu
No. 1 Jianshe East Road
Zhengzhou, 450000, China
Zhengzhou, 450000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Clinical features and prognostic factors of intravascular large B-cell lymphoma: a cohort study of 20 patients from 2018 to 2024.
Journal: The oncologist
Published: January 16, 2025
Modified R-BAC plus BTK inhibitor regimen in newly diagnosed young patients with mantle cell lymphoma: a real-world retrospective study.
Journal: Annals of hematology
Published: November 13, 2023
USP19 exerts a tumor-promoting role in diffuse large B cell lymphoma through stabilizing PARK7.
Journal: The FEBS journal
Published: November 02, 2023
Identification and Validation of a DNA Damage Repair-Related Signature for Diffuse Large B-Cell Lymphoma.
Journal: BioMed research international
Published: July 18, 2022
The Synchronous Presence of Multiple Myelomas and Other Primary Malignant Tumors: Case Series with Literature Review.
Journal: Cancer management and research
Published: November 12, 2019
Efficacy of dose-adjusted EPOCH plus rituximab/R-CHOP regimens and the prognosis analysis in patients with MYC, BCL2/BCL6 gene copy number gain lymphoma and double-hit lymphoma: results from a single institution retrospective clinical study.
Journal: Cancer management and research
Published: February 28, 2019
Clinical efficacy of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) in the initial treatment of advanced stage (stage III-IV) extranodal NK/T-cell lymphoma, and its correlation with Epstein-Barr virus.
Journal: Cancer management and research
Published: October 24, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026